Search

Brazil: Farnesene Production DSM Acquires Amyris Brasil

Editor: Alexander Stark

Royal DSM and Amyris announced that they have closed the transaction for the sale of Amyris Brasil to DSM and the establishment of a long-term manufacturing partnership for Amyris’s high-volume products.

Related Companies

DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris
DSM expands strategic alliance with Amyris and acquires Brazilian production facility from Amyris
(Source: CC0 Pixabay)

Heerlen/The Netherlands — The consideration for Amyris Brasil (which owns and operates the Brotas 1 fermentation facility) and intellectual property related to farnesene (a bio-based key intermediate for many applications) is $ 58 million plus an additional value share arrangement over a three-year period amounting to $ 37.5 million (aggregate upfront consideration of $ 96 million). In addition to the consideration upfront, there is potential for a future value share in line with Amyris’ business model.

With the acquisition of the Brotas 1 facility, DSM adds a state-of-the-art biotechnology-based production site in Brazil to its global network, with abundant availability of sustainable raw materials (sugar cane), securing production capacity for its rich pipeline of sustainable and bio-based solutions. Having broad experience in operating large-scale fermentation plants, DSM will optimize the operational performance of the site.

(ID:45070183)